DRUG · Unmapped registry intervention
Arformoterol tartrate inhalation solution
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects
NCT02275481
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Tiotropium
Normalized identity: tiotropiumView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
TiotropiumDRUG · verified · RxNorm: tiotropium
Sponsors & collaborators
Sumitomo Pharma America, Inc.lead sponsor
Mapped research locations
BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1San AntonioTexas, United States1NashvilleTennessee, United States1SeattleWashington, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1ColumbusOhio, United States1Washington D.C.District of Columbia, United States1OmahaNebraska, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02275481 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.